Mrs. Olivia Maurel PharmD

Head of Global Regulatory Affairs

Zürich, CH

Global pharmaceutical executive with 25 years’ experience in R&D specializing in Regulatory Affairs and Pharmacovigilance.

September 2021 – present
Sobi - Swedish Orphan Biovitrum AB (publ)
Head of Global Regulatory Affairs
April 2021 – November 2021
Takeda
Vice-President, Rare Diseases Global Regulatory Affairs at Takeda
May 2019 – April 2021
Takeda
Vice President, head of Regions and Advertising & Promotion, Global Regulatory Affairs
August 2018 – May 2019
Shire
Vice-President, Head of Global Drug Safety Surveillance
June 2016 – August 2018
Shire
Vice-President, Global Therapeutic area head, GI, Endocrinology, Metabolism & Hematology
May 2013 – May 2016
Shire
Vice President, Global Therapeutic Area head, GI, Endocrinology, Metabolism and Complement Biology,
September 2012 – April 2013
Shire
Senior Director, Head of Global Regulatory Strategy, Rare Diseases, Shire
May 2009 – March 2011
NovImmune
Head of Global Regulatory Affairs
April 2003 – March 2009
Centocor BV
Head of Regulatory Strategy and Product Management group; head of European Regulatory Affairs
January 2001 – January 2003
Genzyme Europe BV
Regulatory Affairs P. Manager
January 1997 – January 2001
Institut de Recherches Internationales Servier
Regulatory Affairs Project. Manager
January 1995 – December 1996
Sanofi Research
Regulatory Affairs Officer